MADISON – Exact Sciences shares inch lower after earnings, stock sale reports

Shares of Exact Sciences Corp. stock slid 7 percent on Tuesday after the Madison company announced a wider loss in its quarterly earnings report along with plans to sell more shares.

The stock closed at $25.15, down $1.88. But at least two analysts issued upbeat notes, reiterating their projections that shares will rise to the mid-$30 range for the maker of the Cologuard non-invasive DNA test for colorectal cancer.

Read more.

Sign up for the BizTimes email newsletter

Stay up-to-date on the people, companies and issues that impact business in Milwaukee and Southeast Wisconsin

What's New

BizPeople

Sponsored Content

Stay up-to-date with our free email newsletter

Keep up with the issues, companies and people that matter most to business in the Milwaukee metro area.

By subscribing you agree to our privacy policy.

No, thank you.
BizTimes Milwaukee